Sponsored Links
| Enzon To Begin Phase 1 Study Of Novel Androgen Receptor MRNA Antagonist In Castration-Resistant Prostate Cancer |
 |
 |
 |
| Medical News - Clinical Trials and Drug Trials | |||
|
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced the Investigational New Drug (IND) approval by the US Food and Drug Administration (FDA) and plan to commence enrollment into a Phase 1a/1b study shortly... Read more: Clinical Trials / Drug Trials News From Medical News Today
|